We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

593 hedge funds and large institutions have $2.46B invested in iShares US Medical Devices ETF in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 167 increasing their positions, 234 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 37.87%37.95% (+0.08%)

6% less funds holding

Funds holding: 632593 (-39)

17% less capital invested

Capital invested by funds: $2.96B → $2.46B (-$504M)

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

27% less call options, than puts

Call options by funds: $14.6M | Put options by funds: $19.9M

29% less repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 234

39% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 84

Holders
593
Holders Change
-39
Holders Change %
-6.17%
% of All Funds
9.99%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.3%
New
51
Increased
167
Reduced
234
Closed
84
Calls
$14.6M
Puts
$19.9M
Net Calls
-$5.36M
Net Calls Change
-$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
CAAS
151
Capital Asset Advisory Services
Michigan
$2.28M +$87.4K +1,603 +4%
VF
152
Virtu Financial
New York
$2.27M +$2.46M +45,054 New
CA
153
Cetera Advisors
Colorado
$2.27M -$72.3K -1,327 -3%
BWL
154
Bogart Wealth LLC
Virginia
$2.25M +$60.4K +1,108 +3%
BAM
155
Belpointe Asset Management
Nevada
$2.22M +$13.4K +246 +0.6%
CAM
156
Cypress Asset Management
Texas
$2.11M
P
157
Palladiem
Pennsylvania
$2.11M -$16.2K -297 -0.7%
HI
158
Harbour Investments
Wisconsin
$2.1M +$2.27M +41,603 New
TRCT
159
Tower Research Capital (TRC)
New York
$2.08M +$713K +13,078 +47%
CFD
160
Creative Financial Designs
Indiana
$2.04M +$106K +1,951 +5%
PA
161
Pinnacle Associates
New York
$2.01M -$85.6K -1,570 -4%
PWS
162
Peterson Wealth Services
Utah
$2M +$78.8K +1,445 +4%
JWCA
163
J.W. Cole Advisors
Florida
$1.98M -$295K -5,411 -12%
SS
164
Sunbelt Securities
Texas
$1.96M +$754K +13,836 +55%
HBW
165
Hazlett, Burt & Watson
West Virginia
$1.88M +$84.4K +1,548 +4%
AIA
166
Armor Investment Advisors
North Carolina
$1.87M +$37.9K +695 +2%
Citadel Advisors
167
Citadel Advisors
Florida
$1.84M -$2.03M -37,321 -51%
MA
168
Mutual Advisors
Nebraska
$1.84M +$207K +3,806 +12%
CWM
169
Circle Wealth Management
New Jersey
$1.84M +$872 +16 +0%
IAN
170
Integrated Advisors Network
Texas
$1.84M +$34.3K +630 +2%
CAG
171
Csenge Advisory Group
Florida
$1.83M +$740K +13,576 +60%
AG
172
Ascent Group
Virginia
$1.83M +$1.86M +34,067 New
TCMP
173
Thrive Capital Management (Pennsylvania)
Pennsylvania
$1.83M -$50.1K -920 -2%
MBT
174
Montecito Bank & Trust
California
$1.81M +$25.2K +463 +1%
CSWG
175
Cardinal Strategic Wealth Guidance
Kentucky
$1.79M +$498K +9,138 +35%

IHI Hedge Fund Activity: Q2 2022 in Review

593 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2022, worth a combined $2.46B — down 17% from $2.96B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of IHI and 51 opened new positions — a net loss of 33 holders — while 234 trimmed existing stakes and 167 added.

The largest buyer was AssetMark Inc, adding an estimated $78.4M. The largest seller was CFS Investment Advisory Services, cutting an estimated $88.9M.

  • 593 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2022, down from 632 in Q1 2022.
  • Funds reported $2.46B of iShares US Medical Devices ETF stock for Q2 2022, down 17% quarter-over-quarter.
  • 51 funds opened new iShares US Medical Devices ETF positions in Q2 2022 and 84 closed out, a net change of -33 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2022 was AssetMark Inc, an estimated $78.4M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2022 was CFS Investment Advisory Services, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2022.